FDA approves catheter for AF ablation

Candace Stuart | February 28, 2014 | Cardiovascular Business | Heart Rhythm

The FDA approved a therapeutic catheter that can be used to measure contact force during cardiac ablation.

The THERMOCOOL SMARTTOUCH catheter is applied in ablation procedures using radiofrequency energy as a treatment for atrial fibrillation (AF). Manufacturer Biosense Webster claims the device provides direct, real-time quantitative feedback displayed graphically on a mapping and navigation system to assist electrophysiologists during a catheter ablation.

The pivotal SMART-AF Investigational Device Exemption clinical trial assessed the safety and effectiveness of the device. The results, presented in 2013 at the Heart Rhythm Society's Scientific Session, showed the trial met its safety and effectiveness endpoints, with 72 percent of patients remaining free from recurrence of AF at 12-month follow-up.

Candace Stuart, Contributor

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

FDA approves catheter for AF ablation

Related Content

Around the web